|
nasdaq:rlyp
|
9273607
|
Dec 19th, 2023 12:00AM
|
Relypsa
|
8.4K
|
73.00
|
Open
|
|
Dec 18th, 2023 10:56PM
|
Dec 18th, 2023 10:56PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 18th, 2023 12:00AM
|
Relypsa
|
8.4K
|
73.00
|
Open
|
|
Dec 17th, 2023 11:47PM
|
Dec 17th, 2023 11:47PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 17th, 2023 12:00AM
|
Relypsa
|
8.4K
|
73.00
|
Open
|
|
Dec 17th, 2023 01:04AM
|
Dec 17th, 2023 01:04AM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 16th, 2023 12:00AM
|
Relypsa
|
8.4K
|
73.00
|
Open
|
|
Dec 15th, 2023 10:55PM
|
Dec 16th, 2023 06:11PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 15th, 2023 12:00AM
|
Relypsa
|
8.4K
|
73.00
|
Open
|
|
Dec 14th, 2023 11:01PM
|
Dec 15th, 2023 01:52PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 14th, 2023 12:00AM
|
Relypsa
|
8.4K
|
74.00
|
Open
|
|
Dec 13th, 2023 11:04PM
|
Dec 14th, 2023 06:48PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 13th, 2023 12:00AM
|
Relypsa
|
8.4K
|
74.00
|
Open
|
|
Dec 12th, 2023 11:15PM
|
Dec 13th, 2023 09:58AM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 12th, 2023 12:00AM
|
Relypsa
|
8.4K
|
74.00
|
Open
|
|
Dec 11th, 2023 11:29PM
|
Dec 12th, 2023 06:46PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 11th, 2023 12:00AM
|
Relypsa
|
8.4K
|
74.00
|
Open
|
|
Dec 10th, 2023 11:09PM
|
Dec 11th, 2023 06:21PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|
|
nasdaq:rlyp
|
9273607
|
Dec 9th, 2023 12:00AM
|
Relypsa
|
8.4K
|
74.00
|
Open
|
|
Dec 9th, 2023 01:02AM
|
Dec 9th, 2023 05:18PM
|
Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies.
Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science.
Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones.
(Our community guidelines: viforpharma.com/linkedin-cg)
|
Open
|
Polymer-based drug discovery, development, and commercialization
|
Open
|
100 Cardinal Way
|
Redwood City
|
CA
|
US
|
94063
|
|
Relypsa
|
|
Health Care Equipment & Services
|